Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition

Rueil-malmaison,,France,-,August,13,,2023:,French,Headquarters,Of,Bristol-myers

Bristol Myers Squibb & Co. (NYSE:BMY) on Friday agreed to acquire Orbital Therapeutics, a privately held biotechnology company focused on RNA medicines that reprogram the immune system in vivo.

The US drug giant agreed to pay $1.5 billion in cash.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.